Baillie Gifford & CO Sana Biotechnology, Inc. Transaction History

Baillie Gifford & CO

$127 Billion
Q4 2024

A detailed history of Baillie Gifford & CO transactions in Sana Biotechnology, Inc. stock. As of the latest transaction made, Baillie Gifford & CO holds 10,233,573 shares of SANA stock, worth $26.4 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

10,233,573

Previous 10,278,084 0.43%

Holding current value

$26.4 Million

Previous $42.8 Million 60.99%

% of portfolio

0.01%

Previous 0.03%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 31, 2025	SELL	$1.6 - $4.36 $71,217 - $194,067	-44,511 Reduced 0.43%	10,233,573 $16.7 Million
Q3 2024 Nov 05, 2024	SELL	$3.76 - $6.86 $1.1 Million - $2.01 Million	-293,116 Reduced 2.77%	10,278,084 $42.8 Million
Q2 2024 Jul 25, 2024	SELL	$5.23 - $10.44 $444,963 - $888,224	-85,079 Reduced 0.8%	10,571,200 $57.7 Million
Q1 2024 May 01, 2024	BUY	$4.2 - $11.27 $2.13 Million - $5.71 Million	506,262 Added 4.99%	10,656,279 $107 Million
Q4 2023 Jan 26, 2024	SELL	$2.8 - $4.55 $152,202 - $247,328	-54,358 Reduced 0.53%	10,150,017 $41.4 Million
Q3 2023 Nov 13, 2023	SELL	$3.77 - $6.23 $2.38 Million - $3.94 Million	-631,786 Reduced 5.83%	10,204,375 $39.5 Million
Q2 2023 Jul 28, 2023	SELL	$3.22 - $7.53 $131,272 - $306,983	-40,768 Reduced 0.37%	10,836,161 $64.6 Million
Q1 2023 May 03, 2023	BUY	$3.11 - $4.92 $348,948 - $552,033	112,202 Added 1.04%	10,876,929 $35.6 Million
Q4 2022 Jan 24, 2023	SELL	$3.19 - $6.46 $644,408 - $1.3 Million	-202,009 Reduced 1.84%	10,764,727 $42.5 Million
Q3 2022 Oct 27, 2022	SELL	$5.58 - $9.04 $249,571 - $404,323	-44,726 Reduced 0.41%	10,966,736 $65.8 Million
Q2 2022 Aug 08, 2022	SELL	$4.12 - $9.35 $306,523 - $695,630	-74,399 Reduced 0.67%	11,011,462 $70.8 Million
Q1 2022 May 05, 2022	SELL	$5.24 - $15.58 $923,125 - $2.74 Million	-176,169 Reduced 1.56%	11,085,861 $91.6 Million
Q4 2021 Jan 20, 2022	BUY	$15.18 - $23.15 $1.1 Million - $1.67 Million	72,198 Added 0.65%	11,262,030 $174 Million
Q3 2021 Oct 19, 2021	SELL	$16.29 - $25.88 $847,389 - $1.35 Million	-52,019 Reduced 0.46%	11,189,832 $252 Million
Q2 2021 Aug 02, 2021	BUY	$16.65 - $32.14 $20.9 Million - $40.3 Million	1,254,306 Added 12.56%	11,241,851 $221 Million
Q1 2021 May 06, 2021	BUY	$23.04 - $43.5 $230 Million - $434 Million	9,987,545 New	9,987,545 $334 Million

Others Institutions Holding SANA

# of Institutions

178

Shares Held

122M

Call Options Held

1.77M

Put Options Held

901K

View Full List

About Sana Biotechnology, Inc.

Ticker SANA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 190,232,000
Market Cap $491M
Description
Sana Biotechnology, Inc., a biotechnology company, focuses on utilizing engineered cells as medicines. The company develops ex vivo and in vivo cell engineering platforms for various therapeutic areas with unmet treatment needs, including oncology, diabetes, central nervous system disorders, cardiovascular diseases, genetic disorders, and others...

More about SANA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Baillie Gifford & CO, based on Form 13F filings with the SEC.

News

Stay updated on Baillie Gifford & CO with notifications on news.

Account

Baillie Gifford & CO Sana Biotechnology, Inc. Transaction History